GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kwality Pharmaceuticals Ltd (BOM:539997) » Definitions » Debt-to-Equity

Kwality Pharmaceuticals (BOM:539997) Debt-to-Equity : 0.43 (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Kwality Pharmaceuticals Debt-to-Equity?

Kwality Pharmaceuticals's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹868 Mil. Kwality Pharmaceuticals's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹157 Mil. Kwality Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Sep. 2024 was ₹2,410 Mil. Kwality Pharmaceuticals's debt to equity for the quarter that ended in Sep. 2024 was 0.43.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Kwality Pharmaceuticals's Debt-to-Equity or its related term are showing as below:

BOM:539997' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.15   Med: 0.53   Max: 0.89
Current: 0.43

During the past 11 years, the highest Debt-to-Equity Ratio of Kwality Pharmaceuticals was 0.89. The lowest was 0.15. And the median was 0.53.

BOM:539997's Debt-to-Equity is ranked worse than
62.39% of 827 companies
in the Drug Manufacturers industry
Industry Median: 0.27 vs BOM:539997: 0.43

Kwality Pharmaceuticals Debt-to-Equity Historical Data

The historical data trend for Kwality Pharmaceuticals's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kwality Pharmaceuticals Debt-to-Equity Chart

Kwality Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.76 0.67 0.30 0.45 0.44

Kwality Pharmaceuticals Quarterly Data
Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.49 N/A 0.44 N/A 0.43

Competitive Comparison of Kwality Pharmaceuticals's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Kwality Pharmaceuticals's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kwality Pharmaceuticals's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kwality Pharmaceuticals's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Kwality Pharmaceuticals's Debt-to-Equity falls into.



Kwality Pharmaceuticals Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Kwality Pharmaceuticals's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Kwality Pharmaceuticals's Debt to Equity Ratio for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kwality Pharmaceuticals  (BOM:539997) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Kwality Pharmaceuticals Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Kwality Pharmaceuticals's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Kwality Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
Majitha Road, Village Nagkalan, 6th Mile Stone, Amritsar, PB, IND, 143601
Kwality Pharmaceuticals Ltd is an India-based pharmaceutical company. It is principally engaged in manufacturing finished pharmaceutical formulations in a dosage form. The company manufactures and exports pharmaceutical formulations in liquid orals, dry syrups, tablets, capsules, sterile powder for injections, and small-volume injectables.

Kwality Pharmaceuticals Headlines

No Headlines